FDA approval, Up AH 114%
BioCardia Shares More Than Double After FDA Approves Medical Instrument Morph DNA Steerable Introducer.....08/28/24
Also, previous PR:
H.C. Wainwright Maintains BioCardia(BCDA.US) With Buy Rating, Raises Target Price to $25....08/22/24
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment